RVLP - RVL Pharmaceuticals plc GAAP EPS of -$0.16 in-line revenue of $10.02M in-line November, 10 2022 04:18 PM RVL Pharmaceuticals plc RVL Pharmaceuticals plc press release ( NASDAQ: RVLP ): Q3 GAAP EPS of -$0.16 in-line. Revenue of $10.02M (+357.5% Y/Y) in-line. For further details see: RVL Pharmaceuticals plc GAAP EPS of -$0.16 in-line, revenue of $10.02M in-line